All In MedTech

Device Trial Radar · NCT02769273

Stellarex Vascular E-Registry

Last checked: Nov 19, 2026Latest source record: Aug 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

1,900

Actual

Start

Jun 2016

Primary completion

Oct 31, 2021

Study completion Dec 2021

Sponsor

Lead sponsor
Spectranetics CorporationNot on our public-company list
Sponsor type
Industry
First posted
May 11, 2016

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective, international, multi-center, single arm, observational study to continue to assess the treatment by the Stellarex™ OTW Drug-coated Angioplasty Balloon in superficial femoral and/or popliteal arteries according to the Instructions for Use in a broad, real-world, claudicant or ischemic rest pain patients population per the institution's standard practice.

Conditions

  • Peripheral Arterial Disease

Interventions

  • Percutaneous Transluminal AngioplastyDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Efficacy Endpoint Cohort 1 - RCC 2-3:Time frame: 12 months post-procedure
  2. Primary Safety Endpoint-Cohort 1 - RCC 2-3Time frame: 30 days post-procedure - 12Month post procedure
  3. Primary effectiveness endpoint: Cohort 2 - RCC 4-6 (CLI)Time frame: 6 Months post procedure

1 more outcomes with a free account

Locations

46 sites in 6 countries. Site status is shown where the registry gives one.

  • Medical University Graz

    Graz, Austria

  • Krankenhaus der Barmherzigen Schwesterrn Reid

    Ried im Innkreis, Austria

  • Krankenhaus Göttlicher Heiland GmbH

    Vienna, Austria

43 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.